(Q41659527)

6 October 2017

1 reference

title

Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment (English)

1 reference

6 October 2017

1

1 reference

6 October 2017

3

1 reference

Gloria Fernández-Esparrach

6 October 2017

series ordinal

2

object named as

Fernández-Esparrach G

1 reference

6 October 2017

publication date

1 June 1997

1 reference

Bailliere's clinical gastroenterology

6 October 2017

published in

1 reference

6 October 2017

volume

11

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

365-385

1 reference

Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

A rational approach to the treatment of ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

A European survey on the treatment of ascites in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Circulating levels of endothelin in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Intestinal microvascular adaptation to chronic portal hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Increased nitric oxide—dependent vasorelaxation in aortic rings of cirrhotic rats with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Pharmacotherapy of ascites associated with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Elevated circulating plasma endothelin-1 concentrations in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Increased production of cysteinyl leukotrienes in hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

The diuretic response to administered water in patients with liver disease. p. II. Laennec's cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITES

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Sulindac Reduces the Urinary Excretion of Prostaglandins and Impairs Renal Function in Cirrhosis with Ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Clinical types and drug therapy of renal impairment in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. II. FACTORS INFLUENCING MAXIMAL URINARY FLOW RATE

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Plasma levels of brain natriuretic peptide in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2897%2990045-2

7 January 2021

10.1016/S0950-3528(97)90045-2

Identifiers

DOI

1 reference

6 October 2017

1 reference